Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Cash Flow Quality Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Quality Index of 0.11x as of December 2023. Operating cash flow of CN¥26.95 Million is below net income of CN¥243.07 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Xinxiang Tuoxin Pharmaceutical Co.Ltd. balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Xinxiang Tuoxin Pharmaceutical Co.Ltd. to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2023)
Year-by-year earnings quality comparison for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For live market cap and the full company financial profile, see market value of Xinxiang Tuoxin Pharmaceutical Co.Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.11x | CN¥26.95 Million | CN¥243.07 Million | ▼ -88.2% |
| 2022 | 0.94x | CN¥268.85 Million | CN¥286.54 Million | ▲ +5.9% |
| 2021 | 0.89x | CN¥58.19 Million | CN¥65.71 Million | ▼ -16.8% |
| 2020 | 1.06x | CN¥120.00 Million | CN¥112.80 Million | ▼ -24.6% |
| 2019 | 1.41x | CN¥86.38 Million | CN¥61.25 Million | — |